Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-697-4 | CAS number: 124-40-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: no guideline followed, well documented experimental result
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 984
Materials and methods
- Objective of study:
- absorption
- excretion
- other: secretion
- Principles of method if other than guideline:
- no guideline followed, details on method are given below
- GLP compliance:
- no
Test material
- Reference substance name:
- Dimethylamine
- EC Number:
- 204-697-4
- EC Name:
- Dimethylamine
- Cas Number:
- 124-40-3
- Molecular formula:
- C2H7N
- IUPAC Name:
- N-methylmethanamine
- Details on test material:
- details are given below
Constituent 1
- Radiolabelling:
- not specified
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Male 15- to 20-week-old Wistar rats were fed a commercial diet containing 23.6 mg/kg DMA or a low-DMA diet containing 1.0 mg/kg DMA. The breeding room was maintained at 25 C and 60% humidity. The components of the low-DMA diet were 68% corn starch, 20% soy casein, 5% soya bean oil, 2% cellulose, 4% minerals and 1% vitamin mixture.
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- The low-DMA diet or the commercial diet and tap water were given freely to rats for one week prior to sacrifice.
- Duration and frequency of treatment / exposure:
- details are given below
Doses / concentrations
- Remarks:
- Doses / Concentrations:
details are given below
- No. of animals per sex per dose / concentration:
- details are given below
- Control animals:
- not specified
- Positive control reference chemical:
- details are given below
- Details on study design:
- details are given below
- Details on dosing and sampling:
- Rats were anaesthetized by intraperitoneal injection of sodium pentobarbital, and the stomach, the small intestine, the caecum and the large intestine were separated. The small intestine was cut into four equal lengths. The intestinal contents were washed out with 10 mL 0.05 mol/L hydrochloric acid. Blood was obtained by cardiac puncture. Killing was carried out in the morning.
Absorption, secretion and excretion tests
Rats fed the commercial diet were fasted overnight and anaesthetized. The abdomen was opened and the stomach and the caecum were ligated at both ends without closing the blood vessels. The upper and lower small intestine and the large intestine were separated into sections of about 5 cm in length by ligation. The site of the ligated section in the upper small intestine was 10 cm from the pylorus and that in the lower small intestine 10 cm from the ileo-caecal valve; 250 µg DMA were injected into each ligated section for the absorption tests. After a given time, the ligated sections were removed and the intestinal contents were washed out with 10 mL 0.05 mol/L hydrochloric acid. For the secretion test, an equal dose of DMA was injected through a femoral vein, and the ligated upper small intestine was removed at a given time. Urine in the bladder was collected through a syringe. - Statistics:
- details are given below
Results and discussion
- Preliminary studies:
- details are given below
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- All rates of disappearance of DMA from the stomach and the intestines after injection of 250 µg DMA were monoexponential over 30 min. The biological half-lives were 8.3, 11.6, 31.5 and 11.0 min for the upper small intestine, the lower small intestine, the caecum and the large intestine, respectively. Absorption of DMA from the stomach was barely observable (t1/2 = 198 min).
DMA was not absorbed from the stomach, but was absorbed from the small intestine, the caecum and the large intestine. - Details on distribution in tissues:
- Distribution of DMA in the digestive tract
DMA in the contents of the gastrointestinal tract and in blood was determined after the rats had been fed the commercial or the low-DMA diet for a week. The concentration of DMA in the gastrointestinal tract of the rats fed the commercial diet was high in the upper intestine and low in the lower intestine. When rats were fed the low-DMA diet, the DMA concentration was lowest (1.3 ± 0.5 mg/kg) in the stomach and highest (6.6 + 2.5 mg/kg) in the upper smalt intestine and decreased in the lower small intestine and the caecum. The DMA concentration in the large intestine was higher than that in the caecum in both groups. The concentration of DMA in the contents of each ligated section in the rats fed the low-DMA diet was lower than that of the corresponding section in rats fed the commercial diet. Less than 1 mg/kg DMA was found in blood in both groups. The DMA concentration in the intestinal contents of rats fed the low-DMA diet was higher than that in the diet, but that in the intestinal contents of the rats fed the commercial diet was lower than that in the diet.
- Details on excretion:
- Decrease of DM A levels in blood and intestinal secretion
The initial half-life of DMA in blood was 12.5 min, and the disappearance curve was monoexponential. Urinary DMA concentration increased from 17.3 ± 9.4 mg/kg to 139 + 23 mg/kg in 30 min. DMA was excreted not only in urine but also in the small intestine. The highest concentration of intestinal DMA (15.6 ± 12.6 mg/kg) was observed 15 min after intravenous injection of DMA. When the intestinal DMA level decreased to the basic concentration, the blood DMA increased a little. The half-life for secondary disappearance of DMA in blood was 15.2 min.
Most of the DMA in blood was excreted in the urine in a relatively short time and a small portion was secreted in the intestine.
Metabolite characterisation studies
- Details on metabolites:
- details are given below
Any other information on results incl. tables
Distribution of DMA in the digestive tract
DMA in the contents of the gastrointestinal tract and in blood was determined after the rats had been fed the commercial or the low-DMA diet for a week. The concentration of DMA in the gastrointestinal tract of the rats fed the commercial diet was high in the upper intestine and low in the lower intestine. When rats were fed the low-DMA diet, the DMA concentration was lowest (1.3 ± 0.5 mg/kg) in the stomach and highest (6.6 + 2.5 mg/kg) in the upper smalt intestine and decreased in the lower small intestine and the caecum. The DMA concentration in the large intestine was higher than that in the caecum in both groups. The concentration of DMA in the contents of each ligated section in the rats fed the low-DMA diet was lower than that of the corresponding section in rats fed the commercial diet. Less than 1 mg/kg DMA was found in blood in both groups. The DMA concentration in the intestinal contents of rats fed the low-DMA diet was higher than that in the diet, but that in the intestinal contents of the rats fed the commercial diet was lower than that in the diet.
Gastrointestinal absorption
All rates of disappearance of DMA from the stomach and the intestines after injection of 250 µg DMA were monoexponential over 30 min. The biological half-lives were 8.3, 11.6, 31.5 and 11.0 min for the upper small intestine, the lower small intestine, the caecum and the large intestine, respectively. Absorption of DMA from the stomach was barely observable (t1/2 = 198 min).
Decrease of DM A levels in blood and intestinal secretion
The initial half-life of DMA in blood was 12.5 min, and the disappearance curve was monoexponential. Urinary DMA concentration increased from 17.3 ± 9.4 mg/kg to 139 + 23 mg/kg in 30 min. DMA was excreted not only in urine but also in the small intestine. The highest concentration of intestinal DMA (15.6 ± 12.6 mg/kg) was observed 15 min after intravenous injection of DMA. When the intestinal DMA level decreased to the basic concentration, the blood DMA increased a little. The half-life for secondary disappearance of DMA in blood was 15.2 min.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: low bioaccumulation potential based on study results
After ingestion of DMA an intestinal absorption occurs, follwed by an accumulation into the blood. From here two pathways can be found: excretion via the urine (1; DMA leaved the body), or an intestinal secretion is performed, whereby this is followed one more time by an intestinal absorpition and an accumulation in the blood. - Executive summary:
DMA was not absorbed from the stomach, but was absorbed from the small intestine, the caecum and the large intestine. Absorbed DMA appeared in the blood, then disappeared rapidly. Most of the DMA in blood was excreted in the urine in a relatively short time and a small portion was secreted in the intestine. When rats were fed a commercial diet containing 23.6 mg/kg DMA, the concentration in the gastrointestinal tract was highest in the stomach and decreased from the upper intestine to the lower region. Since the DMA concentration in the lower intestines (about 4 mg/kg) was not affected by ingestion of DMA, most of the DMA ingested with the diet may be absorbed in the small intestine. The highest rate of absorption of DMA was observed in the upper small intestine, and was almost the same as that observed in guinea-pigs (Ishiwata et al., 1977) The DMA found in the caecum and the large intestine may include an endogenous contribution, as reported by Asatoor and Simenhoff (1965) and by Johnson (1977). These authors concluded that intestinal bacteria form DMA from lecithin. The gastrointestinal distribution of DMA in rats fed the low-DMA diet differed considerably from that in rats fed the commercial diet. The highest concentration of DMA (6.6 mg/kg), observed in the upper small intestine of rats fed the low-DMA diet, may be due to intestinal secretion of DMA from the blood. DMA secreted into the small intestine from blood can be re-absorbed. This is a probable explanation for the second maximum concentration of DMA observed in blood 25 min after intravenous injection of DMA. The disappearance rate between 25 and 30 min (t1/2 = 15.2) was almost the same as that between 5 and 15 min. The higher concentration of DMA in the large intestine than in the caecum is considered to be due to the absorption of intestinal moisture. The site of DMA formation can be considered to be the lower digestive tract, although it may not always be the site of the highest DMA concentration.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.